Carotid body tumor other imaging findings: Difference between revisions
| Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
Since [[paragangliomas]] including [[carotid body]] [[tumor]] are of [[neuroendocrine]] origin, they may have [[somatostatin]] surface [[receptor]] which can be detected as an area of intense [[Radiotracer|radio-tracer]] uptake by the Indium-111 octreotide scan. This [[modality]] may be helpful in the [[diagnosis]] of multicentric or metastatic disease. It also may be used after the surgery to look for a residual tumor. | Since [[paragangliomas]] including [[carotid body]] [[tumor]] are of [[neuroendocrine]] origin, they may have [[somatostatin]] surface [[receptor]] which can be detected as an area of intense [[Radiotracer|radio-tracer]] uptake by the Indium-111 octreotide scan. This [[modality]] may be helpful in the [[diagnosis]] of multicentric or [[metastatic]] [[disease]]. It also may be used after the [[surgery]] to look for a residual [[tumor]]. | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
Since [[paragangliomas]] including [[carotid body]] [[tumor]] are of [[neuroendocrine]] origin, they may have [[somatostatin]] surface receptor which can be detected as an area of intense [[radio-tracer]] uptake by the Indium-111 octreotide scan. This scan may be helpful in the [[diagnosis]] of:<ref name="WienekeSmith2009">{{cite journal|last1=Wieneke|first1=Jacqueline A.|last2=Smith|first2=Alice|title=Paraganglioma: Carotid Body Tumor|journal=Head and Neck Pathology|volume=3|issue=4|year=2009|pages=303–306|issn=1936-055X|doi=10.1007/s12105-009-0130-5}}</ref> | Since [[paragangliomas]] including [[carotid body]] [[tumor]] are of [[neuroendocrine]] origin, they may have [[somatostatin]] surface [[receptor]] which can be detected as an area of intense [[Radiotracer|radio-tracer]] uptake by the Indium-111 octreotide scan. This scan may be helpful in the [[diagnosis]] of:<ref name="WienekeSmith2009">{{cite journal|last1=Wieneke|first1=Jacqueline A.|last2=Smith|first2=Alice|title=Paraganglioma: Carotid Body Tumor|journal=Head and Neck Pathology|volume=3|issue=4|year=2009|pages=303–306|issn=1936-055X|doi=10.1007/s12105-009-0130-5}}</ref> | ||
* Multicentric [[tumor]] | * Multicentric [[tumor]] | ||
* [[Metastatic]] disease | * [[Metastatic]] [[disease]] | ||
* Residual [[tumor]] after the [[surgery]] | * Residual [[tumor]] after the [[surgery]] | ||
The scan is | The scan is sensitive for [[tumors]] greater than 1.5 cm. | ||
==References== | ==References== | ||
Revision as of 14:52, 12 April 2019
|
Carotid body tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carotid body tumor other imaging findings On the Web |
|
American Roentgen Ray Society Images of Carotid body tumor other imaging findings |
|
Risk calculators and risk factors for Carotid body tumor other imaging findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Since paragangliomas including carotid body tumor are of neuroendocrine origin, they may have somatostatin surface receptor which can be detected as an area of intense radio-tracer uptake by the Indium-111 octreotide scan. This modality may be helpful in the diagnosis of multicentric or metastatic disease. It also may be used after the surgery to look for a residual tumor.
Other Imaging Findings
Since paragangliomas including carotid body tumor are of neuroendocrine origin, they may have somatostatin surface receptor which can be detected as an area of intense radio-tracer uptake by the Indium-111 octreotide scan. This scan may be helpful in the diagnosis of:[1]
- Multicentric tumor
- Metastatic disease
- Residual tumor after the surgery
The scan is sensitive for tumors greater than 1.5 cm.
References
- ↑ Wieneke, Jacqueline A.; Smith, Alice (2009). "Paraganglioma: Carotid Body Tumor". Head and Neck Pathology. 3 (4): 303–306. doi:10.1007/s12105-009-0130-5. ISSN 1936-055X.